A federal court hearing has been scheduled regarding the Trump administration’s decision to give states the power to enforce work requirements on Medicaid enrollees.

Despite claims otherwise from President Donald Trump, the Affordable Care Act remains the law of the land—though federal actions have increased instability in the ACA’s marketplaces. Following last year’s repeal of the individual mandate, insurers are now offering short-term, non-ACA-compliant policies, which could leave a sicker, older population shopping on ACA marketplaces.

Officials from HHS are currently talking with pharmaceutical companies to pursue voluntary price cuts as part of President Donald Trump’s drug pricing plan, The Hill reports.

Five months before the 2018 midterm elections, California Republicans see their opponents’ embrace of exploring single-payer healthcare as an opportunity.

On Monday, June 11, CMS released guidance for states to leverage Medicaid in fighting opioid abuse and misuse—with the document making specific mention of efforts to reduce negative impact in infants and outlining potential benefits of health information technology.

Private equity firm KKR & Co. announced its plan to buy Envision Healthcare for $5.57 billion and debt. The all-cash transaction will value Envision at $9.9 billion, according to Bloomberg.

Stryker approached Boston Scientific with a takeover bid on Monday, June 11, according to the Wall Street Journal.

Nancy Pelosi didn’t endorse any single-payer proposals as other Democrats have in the Senate, though she did reiterate her support for a government-run insurance option.